# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 21, "Diabetes Obes Metab .", "", "<http://ctro/data#Publication_33909> <http://ctro/data#hasJournal> \"Diabetes Obes Metab .\"."
1, PublicationYear, 22, 26, "2011", "", "<http://ctro/data#Publication_33909> <http://ctro/data#hasPublicationYear> \"2011\"."
22, Title, 112, 319, "Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal - bolus therapies with insulin lispro in type 2 diabetes patients : a prospective randomized open - label trial .", "", "<http://ctro/data#Publication_33909> <http://ctro/data#hasTitle> \"Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal - bolus therapies with insulin lispro in type 2 diabetes patients : a prospective randomized open - label trial .\"."
180, LisproProtamine, 126, 161, "insulin lispro protamine suspension", "", 
3, InsulinGlargine, 169, 185, "insulin glargine", "", 
4, Frequency, 186, 196, "once daily", "", 
106314, Precondition, 229, 271, "insulin lispro in type 2 diabetes patients", "", "<http://ctro/data#Population_33932> <http://ctro/data#hasPrecondition> \"insulin lispro in type 2 diabetes patients\"."
5, Lispro, 229, 243, "insulin lispro", "", 
6, Type2Diabetes, 247, 262, "type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
60975, Prospective, 276, 287, "prospective", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
7, Randomized, 288, 298, "randomized", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
9, OpenLabel, 299, 311, "open - label", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
10, Author, 320, 330, "Koivisto V", "", "<http://ctro/data#Publication_33909> <http://ctro/data#hasAuthor> \"Koivisto V\"."
11, Author, 339, 347, "Cleall S", "", "<http://ctro/data#Publication_33909> <http://ctro/data#hasAuthor> \"Cleall S\"."
12, Author, 350, 362, "Pontiroli AE", "", "<http://ctro/data#Publication_33909> <http://ctro/data#hasAuthor> \"Pontiroli AE\"."
13, Author, 365, 376, "Giugliano D", "", "<http://ctro/data#Publication_33909> <http://ctro/data#hasAuthor> \"Giugliano D\"."
14, Germany, 445, 452, "Germany", "", "<http://ctro/data#Population_33932> <http://ctro/data#hasCountry> <http://ctro/data#Germany>."
21, ObjectiveDescription, 492, 684, "To compare the efficacy and safety of insulin lispro protamine suspension ( ILPS ) versus insulin glargine once daily in a basal - bolus regimen in type 2 diabetes mellitus ( T2DM ) patients .", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasObjectiveDescription> \"To compare the efficacy and safety of insulin lispro protamine suspension ( ILPS ) versus insulin glargine once daily in a basal - bolus regimen in type 2 diabetes mellitus ( T2DM ) patients .\"."
181, LisproProtamine, 530, 565, "insulin lispro protamine suspension", "", 
60976, LisproProtamine, 568, 572, "ILPS", "", 
17, InsulinGlargine, 582, 598, "insulin glargine", "", 
18, Frequency, 599, 609, "once daily", "", 
19, Type2Diabetes, 640, 664, "type 2 diabetes mellitus", "", 
20, Type2Diabetes, 667, 671, "T2DM", "", 
23, NumberPatientsCT, 695, 723, "Three hundred eighty - three", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasNumberPatientsCT> \"Three hundred eighty - three\"."
24, Insulin, 724, 731, "insulin", "", 
32, Precondition, 724, 750, "insulin - treated patients", "", 
25, Randomized, 756, 766, "randomized", "", 
183, LisproProtamine, 777, 781, "ILPS", "", "<http://ctro/data#Medication_33982> <http://ctro/data#hasDrug> <http://ctro/data#LisproProtamine>."
27, Lispro, 787, 793, "lispro", "", 
28, InsulinGlargine, 797, 805, "glargine", "", "<http://ctro/data#Medication_33996> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine>."
29, Lispro, 811, 817, "lispro", "", 
30, OpenLabel, 826, 838, "open - label", "", 
31, Duration, 839, 848, "24 - week", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasCTduration> \"24 - week\"."
123, Multicenter, 849, 863, "European study", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
60977, DoseDescription, 866, 936, "Insulin doses were titrated to predefined blood glucose ( BG ) targets", "", 
33, Insulin, 866, 873, "Insulin", "", 
185, BloodGlucose, 908, 921, "blood glucose", "", 
186, BloodGlucose, 924, 926, "BG", "", 
184, LisproProtamine, 960, 964, "ILPS", "", 
35, InsulinGlargine, 972, 980, "glargine", "", 
36, HbA1c, 1080, 1085, "HbA1c", "", 
88, TimePoint, 1091, 1099, "baseline", "", 
87, TimePoint, 1103, 1110, "week 24", "", 
37, HbA1c, 1147, 1152, "HbA1c", "", 
126, Percentage, 1198, 1199, "%", "", 
38, HbA1c, 1231, 1236, "HbA1c", "", 
128, BloodGlucose, 1250, 1252, "BG", "", 
89, InsulinDose, 1264, 1277, "insulin doses", "", 
40, Hypoglycemia, 1280, 1302, "hypoglycaemic episodes", "", 
41, EndPointDescription, 1305, 1319, "adverse events", "", 
42, EndPointDescription, 1324, 1335, "vital signs", "", 
187, LisproProtamine, 1369, 1373, "ILPS", "", 
44, InsulinGlargine, 1381, 1389, "glargine", "", 
45, HbA1c, 1407, 1412, "HbA1c", "", "<http://ctro/data#Endpoint_34021> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
133, TimePoint, 1418, 1426, "baseline", "", 
134, LeastSquaresMean, 1439, 1458, "least - square mean", "", 
60978, ConfIntervalDiff, 1490, 1501, "( 95 % CI )", "", "<http://ctro/data#DiffBetweenGroups_34107> <http://ctro/data#hasConfIntervalDiff> \"( 95 % CI )\". <http://ctro/data#DiffBetweenGroups_34107> <http://ctro/data#hasConfIntervalDiff> \"( - 0 . 11 ; 0 . 31 )\"."
135, DiffGroupAbsValue, 1506, 1511, "0 . 1", "", "<http://ctro/data#DiffBetweenGroups_34107> <http://ctro/data#hasDiffGroupAbsValue> \"0 . 1\"."
49, Percentage, 1512, 1513, "%", "", "<http://ctro/data#Endpoint_34021> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
60978, ConfIntervalDiff, 1514, 1535, "( - 0 . 11 ; 0 . 31 )", "", 
139, Mean, 1538, 1542, "Mean", "", "<http://ctro/data#Mean_34023> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_34021> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_34023>."
90, TimePoint, 1554, 1561, "week 24", "", "<http://ctro/data#Outcome_34026> <http://ctro/data#hasTimePoint> \"week 24\". <http://ctro/data#Outcome_34053> <http://ctro/data#hasTimePoint> \"week 24\"."
52, Reduction, 1569, 1575, "1 . 05", "", "<http://ctro/data#Outcome_34026> <http://ctro/data#hasChangeValue> \"1 . 05\"."
54, Percentage, 1576, 1577, "%", "", 
188, LisproProtamine, 1580, 1584, "ILPS", "", 
53, Reduction, 1593, 1599, "1 . 20", "", "<http://ctro/data#Outcome_34026> <http://ctro/data#hasChangeValue> \"1 . 05\"."
55, Percentage, 1600, 1601, "%", "", 
51, InsulinGlargine, 1604, 1612, "glargine", "", 
56, HbA1c_target, 1617, 1632, "HbA1c < 7 . 0 %", "", "<http://ctro/data#Endpoint_34117> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target>."
145, Percentage, 1631, 1632, "%", "", 
57, PercentageAffected, 1649, 1655, "21 . 7", "", "<http://ctro/data#Outcome_34122> <http://ctro/data#hasPercentageAffected> \"21 . 7\"."
58, PercentageAffected, 1663, 1669, "29 . 4", "", "<http://ctro/data#Outcome_34149> <http://ctro/data#hasPercentageAffected> \"29 . 4\"."
151, Mean, 1686, 1690, "Mean", "", "<http://ctro/data#Mean_34178> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_34176> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_34178>. <http://ctro/data#Mean_34183> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_34181> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_34183>."
60987, InsulinDose, 1691, 1696, "basal", "", 
60990, InsulinDose, 1699, 1721, "mealtime insulin doses", "", "<http://ctro/data#InsulinDose_34182> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#InsulinDose>. <http://ctro/data#Endpoint_34181> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#InsulinDose_34182>."
60987, InsulinDose, 1708, 1721, "insulin doses", "", "<http://ctro/data#InsulinDose_34177> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#InsulinDose>. <http://ctro/data#Endpoint_34176> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#InsulinDose_34177>."
92, TimePoint, 1725, 1732, "week 24", "", "<http://ctro/data#Outcome_34186> <http://ctro/data#hasTimePoint> \"week 24\". <http://ctro/data#Outcome_34213> <http://ctro/data#hasTimePoint> \"week 24\". <http://ctro/data#Outcome_34240> <http://ctro/data#hasTimePoint> \"week 24\". <http://ctro/data#Outcome_34267> <http://ctro/data#hasTimePoint> \"week 24\"."
60, ResultMeasuredValue, 1738, 1744, "29 . 6", "", "<http://ctro/data#Outcome_34186> <http://ctro/data#hasResultMeasuredValue> \"29 . 6\"."
61, ResultMeasuredValue, 1747, 1753, "36 . 2", "", "<http://ctro/data#Outcome_34240> <http://ctro/data#hasResultMeasuredValue> \"36 . 2\"."
60986, BioAndMedicalUnit, 1754, 1762, "IU / day", "", "<http://ctro/data#BioAndMedicalUnit_34179> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_34176> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_34179>. <http://ctro/data#BioAndMedicalUnit_34184> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_34181> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_34184>."
189, LisproProtamine, 1765, 1769, "ILPS", "", 
62, ResultMeasuredValue, 1779, 1785, "32 . 8", "", "<http://ctro/data#Outcome_34213> <http://ctro/data#hasResultMeasuredValue> \"32 . 8\"."
63, ResultMeasuredValue, 1788, 1794, "42 . 2", "", "<http://ctro/data#Outcome_34267> <http://ctro/data#hasResultMeasuredValue> \"42 . 2\"."
60985, BioAndMedicalUnit, 1795, 1803, "IU / day", "", 
67, InsulinGlargine, 1806, 1814, "glargine", "", 
92976, InsulinDose, 1872, 1882, "total dose", "", "<http://ctro/data#InsulinDose_34295> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#InsulinDose>. <http://ctro/data#Endpoint_34294> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#InsulinDose_34295>."
68, PvalueDiff, 1885, 1894, "p = 0 . 7", "", "<http://ctro/data#DiffBetweenGroups_34353> <http://ctro/data#hasPvalueDiff> \"p = 0 . 7\"."
166, PercentageAffected, 1916, 1922, "56 . 1", "", "<http://ctro/data#Outcome_34372> <http://ctro/data#hasPercentageAffected> \"56 . 1\"."
71, PercentageAffected, 1925, 1931, "25 . 7", "", "<http://ctro/data#Outcome_34426> <http://ctro/data#hasPercentageAffected> \"25 . 7\"."
168, PercentageAffected, 1941, 1947, "63 . 6", "", "<http://ctro/data#Outcome_34399> <http://ctro/data#hasPercentageAffected> \"63 . 6\"."
72, PercentageAffected, 1950, 1956, "19 . 3", "", "<http://ctro/data#Outcome_34453> <http://ctro/data#hasPercentageAffected> \"19 . 3\"."
73, NocturnalHypoglycemia, 1989, 2012, "nocturnal hypoglycaemia", "", "<http://ctro/data#Endpoint_34367> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#NocturnalHypoglycemia>."
93014, Hypoglycemia, 1999, 2012, "hypoglycaemia", "", "<http://ctro/data#Endpoint_34362> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia>."
164, Hypoglycemia, 2013, 2012, "", "", 
92984, PvalueDiff, 2015, 2024, "p = 0 . 2", "", "<http://ctro/data#DiffBetweenGroups_34480> <http://ctro/data#hasPvalueDiff> \"p = 0 . 2\". <http://ctro/data#DiffBetweenGroups_34489> <http://ctro/data#hasPvalueDiff> \"p = 0 . 2\"."
80, ConclusionComment, 2112, 2335, "A basal - bolus regimen with ILPS once daily resulted in non - inferior glycaemic control compared to a similar regimen with glargine , without statistically significant or clinically relevant differences in hypoglycaemia .", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasConclusionComment> \"A basal - bolus regimen with ILPS once daily resulted in non - inferior glycaemic control compared to a similar regimen with glargine , without statistically significant or clinically relevant differences in hypoglycaemia .\"."
190, LisproProtamine, 2141, 2145, "ILPS", "", 
77, Frequency, 2146, 2156, "once daily", "", 
78, InsulinGlargine, 2237, 2245, "glargine", "", 
79, Hypoglycemia, 2320, 2333, "hypoglycaemia", "", 
191, LisproProtamine, 2336, 2340, "ILPS", "", 
84, ConclusionComment, 2336, 2450, "ILPS - based regimens can be considered an alternative to basal - bolus regimens with glargine for T2DM patients .", "", "<http://ctro/data#ClinicalTrial_33916> <http://ctro/data#hasConclusionComment> \"ILPS - based regimens can be considered an alternative to basal - bolus regimens with glargine for T2DM patients .\"."
82, InsulinGlargine, 2422, 2430, "glargine", "", 
83, Type2Diabetes, 2435, 2439, "T2DM", "", 
85, PMID, 2545, 2553, "21819517", "", "<http://ctro/data#Publication_33909> <http://ctro/data#hasPMID> \"21819517\"."
